Xtant Medical earned FDA approval for its InTice-C Porous Titanium Cervical Interbody System.
Here are five highlights.
1. The company designed InTice-C using OsteoSync Ti, a cost-effective, highly porous titanium scaffold material for implant fixation.
2. InTice-C's surface resembles the bioscaffold of cancellous bone. The system is also cleared for use with Xtant's allograft lines.
3. Xtant designed the system to offer multiple footprint, height and endplate options. Its commercial pure titanium structure provides continuous pore interconnectivity.
4. Additionally, the cervical interbody system is designed to optimize vascularization at the fusion site, allowing the implant to be a included in the fusion process.
5. InTice-C uses machined endplate structures in conjunction with porous titanium to provide migration resistance. The implant is offered in individual sterile packages.